Periodic Report
CJ Bioscience sold KRW 0.9 billion in Q3 and lost KRW 4.9 billion from its main business, a smaller loss than KRW 6.1 billion a year earlier.
311690 · KOSDAQ · Based on DART filings
1 total · 20 per page
CJ Bioscience sold KRW 0.9 billion in Q3 and lost KRW 4.9 billion from its main business, a smaller loss than KRW 6.1 billion a year earlier.
Get app alerts for new disclosures from CJ Bioscience.